von Schnakenburg C, Byrd D J, Latta K, Reusz G S, Graf D, Brodehl J
Laboratorium für pädiatrische Nieren- und Stoffwechselkrankheiten, Kinderklinik der Medizinischen Hochschule Hannover, Germany.
Eur J Clin Chem Clin Biochem. 1994 Jan;32(1):27-9. doi: 10.1515/cclm.1994.32.1.27.
Evidence for the suitability of spot urines for selective screening in children was obtained by comparing the 24-hour urinary oxalate excretion with the ratio of urinary oxalate to creatinine [mmol/mol] in spontaneously voided urine samples. Spot urines of 169 healthy children aged 1 day to 13 years were analysed in order to establish reference values for the urinary oxalate/creatinine ratio in relation to age and body surface area. Oxalate was measured by automated ion chromatography. Results showed an inverse relationship between the oxalate/creatinine ratio and age. The highest ratios, 131 +/- 57 mmol/mol (mean +/- 2 SD), were found in infants. At age two years, the ratio was 84 +/- 55, at age five years 56 +/- 35, and for children older than ten years 42 +/- 31. This finding can be explained by the gain of muscle mass and hence increased creatinine production with increasing age. Data for the urinary oxalate/creatinine ratio are presented according to body surface area for the assessment of children with abnormal growth. In 19 urine samples from nine patients with primary hyperoxaluria, the oxalate/creatinine ratio greatly exceeded (286-2022 mmol/mol) the above reference ranges. We therefore propose the determination of the oxalate/creatinine ratio in spot urines for the selective screening for hyperoxaluria in children with nephrocalcinosis or urolithiasis.
通过比较24小时尿草酸排泄量与随机尿样中尿草酸与肌酐的比值[mmol/mol],获得了随机尿适用于儿童选择性筛查的证据。对169名年龄在1天至13岁的健康儿童的随机尿样进行分析,以建立尿草酸/肌酐比值与年龄和体表面积相关的参考值。草酸通过自动离子色谱法测定。结果显示草酸/肌酐比值与年龄呈负相关。婴儿的比值最高,为131±57 mmol/mol(平均值±2标准差)。两岁时,比值为84±55,五岁时为56±35,十岁以上儿童为42±31。这一发现可以用随着年龄增长肌肉量增加以及肌酐生成增加来解释。根据体表面积给出了尿草酸/肌酐比值的数据,用于评估生长异常的儿童。在9例原发性高草酸尿症患者的19份尿样中,草酸/肌酐比值大大超过(286 - 2022 mmol/mol)上述参考范围。因此,我们建议测定随机尿中的草酸/肌酐比值,用于对患有肾钙质沉着症或尿路结石的儿童进行高草酸尿症的选择性筛查。